A rare stem cell in the blood, a progenitor, functions as a barometer for macular degeneration activity. The UNC test is able to measure the progress of the disease through the progenitor.
The UNC small pilot test will move forward to a multicenter trial.
More Articles on Ophthalmology:
10 Eye Specialists Earn National Awards for One-Page Proposals
C-Reactive Protein Again Linked to Macular Degeneration
Houston Ophthalmologists Named ‘Best Doctors’
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
